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Abstract
Introduction: Nonfocal transient neurological attacks (TNAs) 
are associated with an increased risk of cardiac events, stroke 
and dementia. Their etiology is still unknown. Global cere-
bral hypoperfusion has been suggested to play a role in their 
etiology, but this has not been investigated. We assessed 
whether lower total brain perfusion is associated with a 
higher occurrence of TNAs. Methods: Between 2015 and 
2018, patients with heart failure were included in the Heart 
Brain Connection study. Patients underwent brain magnetic 
resonance imaging, including quantitative magnetic reso-
nance angiography (QMRA) to measure cerebral blood flow 
(CBF). We calculated total brain perfusion of each participant 
by dividing total CBF by brain volume. Patients were inter-
viewed with a standardized questionnaire on the occurrence 
of TNAs by physicians who were blinded to QMRA flow sta-
tus. We assessed the relation between total brain perfusion 
and the occurrence of TNAs with Poisson regression analysis. 
Results: Of 136 patients (mean age 70 years, 68% men), 29 
(21%) experienced ≥1 TNAs. Nonrotatory dizziness was the 
most common subtype of TNA. Patients with TNAs were 
more often female and more often had angina pectoris than 
patients without TNAs, but total CBF and total brain perfu-
sion were not different between both groups. Total brain 
perfusion was not associated with the occurrence of TNAs 
(adjusted risk ratio 1.12, 95% CI 0.88–1.42). Conclusion: We 
found no association between total brain perfusion and the 
occurrence of TNAs in patients with heart failure. 
© 2019 The Author(s) 
Published by S. Karger AG, Basel
Introduction
Nonfocal transient neurological attacks (TNAs) are 
characterized by an acute onset of neurological signs or 
symptoms, such as unsteadiness, confusion or bilateral 
weakness [1]. In contrast to transient ischemic attacks 
(TIAs), the signs and symptoms of TNAs cannot be at-
tributed to one specific arterial territory of the brain [1, 2]. 
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TNAs are not a diagnostic entity, and the lack of a spe-
cific ICD code for TNA, for example, through the use of 
medical registries, makes it harder to study this topic. 
However, TNAs have been found to be associated with an 
increased risk of cardiac events, stroke, and dementia [1, 
3]. Prevalence rates of TNAs vary highly between popula-
tions, ranging from 2% in the preceding 3 years in healthy 
participants aged 55 years or older to 45% in the preceding 
6 months in patients with a recent TIA or nondisabling 
ischemic stroke with carotid or vertebral artery stenosis 
[4, 5]. In a population-based study, TNAs were associated 
with smoking, hypertension, and angina pectoris [4].
Consensus on the etiology of TNAs and its pathogen-
esis is still lacking. Both transient and chronic global ce-
rebral hypoperfusion have been suggested to be an impor-
tant causal factor [3, 6]. However, as there is no clear evi-
dence to support this hypothesis, debate remains [3, 6]. 
Patients with heart failure are at increased risk of cere-
bral hypoperfusion, which is thought to be mediated 
through a reduced cardiac output, and related to the New 
York Heart Association (NYHA) classification and dura-
tion of heart failure [7–10]. We therefore investigated the 
occurrence of TNAs and their association with cerebral 
perfusion in patients with heart failure. We hypothesized 
that, in these patients, a recent TNA is related to chronic 
global cerebral hypoperfusion. 
Methods
Study Population and Design
Between September 2015 and August 2018, 162 patients 
with heart failure were recruited from cardiology outpatient clin-
ics in the Netherlands. Inclusion criteria were an established di-
agnosis of heart failure that had been clinically stable for at least 
6 months. Heart failure was defined according to the European 
Cardiology Society Guidelines as both symptoms and signs typ-
ical of heart failure with objective evidence of a structural or 
functional abnormality of the heart at rest on routine echocar-
diography [11]. All patients were 50 years or older and indepen-
dent in daily living. Among others, exclusion criteria were a con-
traindication to undergo magnetic resonance imaging (MRI) 
and atrial fibrillation at the moment of inclusion [12]. 
The current study is embedded in the Heart Brain Connec-
tion (HBC) study, a multicenter cohort study that focusses on 
 cardiovascular and hemodynamic contributions to cognitive im-
pairment [12]. Detailed information on the rationale and design 
has been described elsewhere [12]. The HBC study was approved 
by the Ethics Committee at the Leiden University Medical Cen-
ter. All participants provided written informed  consent. 
Patient Characteristics
Patients were assessed by a trained physician or research nurse 
using a standardized interview on demographics, vascular risk fac-
tors, and the occurrence of nonfocal symptoms in the preceding 
6 months (Table 1) [1, 12]. TNAs were defined as attacks of 1 or more 
nonfocal symptoms with an acute onset, a minimum duration of 30 
seconds and a maximum duration of 24 h. The interviewer was blind-
ed to the quantitative magnetic resonance angiography (QMRA) 
flow status. Left ventricular ejection fraction (LVEF) was assessed by 
echocardiography, and characteristics of heart failure were derived 
from medical records. Systolic and diastolic blood pressures were 
measured on the left and right arm with an automatic blood pressure 
monitor; the mean of these 2 readings was used for analyses. 
Assessment of MRI and QMRA Flow Status
Patients underwent brain MRI, including QMRA [13–15]. MRI 
was performed on 3T scanners with a standardized protocol (Phil-
ips Ingenia, Philips Achieva and Philips Gemini; Philips Medical 
Systems, Best, the Netherlands). We acquired T1-weighted 
 sequences (resolution = 1 × 1 × 1 mm3, duration = 6 min 47 s, 
 MP-RAGE; repetition time [TR] = 8.2 ms; echo time [TE] = 4.5 ms; 
shot interval = 3,000 ms; flip angle = 8°; inversion delay = 990 ms) 
and fluid-attenuated inversion recovery sequences (resolution 
1.11 × 1.11 × 1.11 mm3, duration = 4 min 43s, TR = 4,800 ms, TE = 
313 ms, inversion time 1.650 ms, turbo spin-echo factor 182). A 
neuroradiologist, who was blinded to clinical information, rated 
all MRI scans on the presence of brain infarction.
For flow measurement, QMRA was performed [13–15]. On a 
sagittal angiographic MRI scout image, a transverse imaging plane 
perpendicular both to the precavernous portion of the internal ca-
rotid arteries and to the middle part of the basilar artery was chosen 
for a 2D gradient-echo phase contrast sequence (resolution 1.17 × 
1.17 × 5 mm3, duration = 0.43 s, TR = 12 ms, TE = 8.2 ms, flip an-
gle = 10°, velocity encoding = 200 cm/s, untriggered, 10 averages).
Assessment of Brain Volume, Total Cerebral Blood Flow and 
Total Brain Perfusion
For assessment of brain volume, a fully automated brain tissue 
and white matter hyperintensity segmentation method were com-
bined with manual segmentation of brain volumes and infarcts based 
on T1-weighted and fluid attenuated inversion recovery sequencing 
scans [16]. Total brain volume (in mL) was corrected for infarcts and 
calculated by adding up gray and white matter volumes [16].
Total cerebral blood flow (CBF, in mL/min) was calculated 
from the phase-contrast images. Regions of interest were manu-
Table 1. Predefined nonfocal neurological symptoms with occur-
rence of each nonfocal symptom in the past 6 months
Nonfocal symptoms Number (%)
Unconsciousness 4 (14)
Confusion 1 (3)
Amnesia 1 (3)
Unsteadiness 4 (14)
Bilateral leg weakness 2 (7)
Blurred vision 3 (10)
Nonrotatory dizziness 22 (76)
Paresthesias 4 (14)
All symptoms should have an acute onset, a minimum duration 
of 30 s and a maximum duration of 24 h.
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ally drawn closely around the vessel lumens of both internal ca-
rotid arteries and the basilar artery using the flow analysis tool of 
Mass software (Division of Image Processing, Department of Ra-
diology, Leiden University Medical Center, Leiden, The Nether-
lands) [14]. Flow velocities were multiplied by the cross-sectional 
area of the regions of interest to obtain volume flow rates (in mL/
min). The flow through the 3 vessels was then summed to calculate 
total CBF (in mL/min). 
We calculated total brain perfusion (in mL/min per 100 mL) by 
dividing each individual’s total CBF (in mL/min) by brain volume 
(in mL) and multiplying the result by 100.
Statistical Analysis
Descriptive analyses characterize the study population of heart 
failure patients with and without TNAs. Differences were deter-
mined with independent sample t tests, chi-square-tests, or Fish-
er’s exact tests when appropriate. 
We assessed the relation between total brain perfusion and TNAs 
with Poisson regression analysis with robust standard errors (SEs). 
We calculated crude and adjusted risk ratios (RR, expressed per stan-
dard deviation (SD)) with corresponding 95% CIs for the occurrence 
of ≥1 TNAs. Adjustments were made for age, sex, and angina pecto-
ris, as these factors were considered a priori to be potential con-
founders of the association between total brain perfusion and TNAs.
Results
A total of 162 patients with heart failure were included 
in the HBC study. After exclusion of 7 patients (4%) with 
missing questionnaires on nonfocal symptoms and 19 pa-
tients (12%) with unreliable measures of total brain per-
fusion, 136 patients (mean age 69.9 years [SD 9.6], 67.6% 
male) remained for analyses. Characteristics of the study 
population are described in Table 2. Twenty-nine pa-
tients (21%) had experienced ≥1 TNAs in the preceding 
Table 2. Characteristics and QMRA flow status of patients with and without TNAs
No TNA (n = 107) ≥1 TNAs (n = 29) p value
Characteristics
Gender, male 77 (72) 15 (52) 0.04
Age, years 70±10 69±9 0.59
Current smoking 15 (14) 5 (17) 0.91
Diabetes mellitus 18 (17) 3 (10) 0.36
Hyperlipidemia 47 (44) 15 (54) 0.38
Hypertension 55 (51) 16 (57) 0.59
Angina pectoris 14 (13) 12 (41) 0.001
History
Myocardial infarction 54 (50) 16 (55) 0.65
TIA 8 (8) 5 (17) 0.11
Ischemic stroke 5 (5) 2 (7) 0.63
Blood pressure, mm Hg
Systolic 135±18 135±16 1.00
Diastolic 76±10 77±13 0.71
NYHA classification 0.35
Class I 49 (46) 8 (28)
Class I–II 17 (16) 6 (21)
Class II 30 (28) 13 (45)
Class II–III 6 (6) 1 (3)
Class III 5 (5) 1 (3)
Duration of heart failure, years 4±1 3±1 0.18
LVEF (percentages) 43±8 44±9 0.47
MRI/QMRA findings
Visible brain infarcts 44 (41) 11 (38) 0.76
Total CBF, mL/min 556±159 592±164 0.29
Total brain volume, mL 1,093±109 1,077±115 0.55
Total brain perfusion, mL/min/100 mL 51.2±15.2 54.9±13.7 0.25
Numbers are n (%) or mean ± SD. 
MRI/QMRA, magnetic resonance imaging/quantitative magnetic resonance angiography; TNA, nonfocal 
transient neurological attack; TIA, transient ischemic attack; NYHA, New York Heart Association; LVEF, left 
ventricular ejection fraction; CBF, cerebral blood flow.
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6 months. Of these 29 patients, 21 patients experienced 1 
TNA and 8 patients experienced 2 or more TNAs (me-
dian 1, interquartile range 1–2). Nonrotatory dizziness 
was the most common subtype of TNA (Table 1). Patients 
with TNAs were more often female (48 vs. 28%, p = 0.039) 
and more often had angina pectoris (41 vs. 13%, p = 0.001) 
than patients without TNAs. Patients with and without 
TNAs were comparable with respect to age and vascular 
risk factors. Furthermore, LVEF, duration of heart fail-
ure, and NYHA classification did not differ between pa-
tients with and without TNAs.
Total CBF, total brain volume, and total brain perfu-
sion were similar between patients with and without 
TNAs (Table 2). Total brain perfusion was not associated 
with the occurrence of TNAs (crude RR 1.20, 95% CI 
0.92–1.56; adjusted RR 1.12, 95% CI 0.88–1.42). 
Discussion
This study shows that, in heart failure patients, there is 
no difference in total brain perfusion as measured by 
QMRA between patients with and without TNAs. Our 
results do not support the often-presumed hypothesis 
that global cerebral hypoperfusion is associated with the 
occurrence of TNAs. 
Most previous studies that focused on the etiology of 
TNAs have investigated the relation between TNAs and 
different markers of cardiac disease [3, 6, 17]. Even though 
TNAs were associated with a higher risk of major cardiac 
events than TIAs, NT-proBNP levels were not signifi-
cantly higher in patients with TNAs than in patients with 
TIAs [3, 6]. These findings are comparable with our re-
sults, as duration of heart failure, LVEF, and NYHA clas-
sification did not differ between patients with and with-
out TNAs. Furthermore, previous studies found no rela-
tion between TNAs and arrhythmias on 24-h ECG 
monitoring, nor between TNAs and atrial fibrillation [4, 
17, 18]. In our study, known atrial fibrillation was an ex-
clusion criterion, but the incidence of TNAs was still rel-
atively high among patients with heart failure. Further-
more, we found no difference in visible brain infarcts on 
MRI between patients with and without TNAs, support-
ing previous findings that the role of cardio-embolism in 
the etiology of TNAs is relatively small. 
Another study found acute focal cerebral ischemia as 
measured with MR diffusion weighted imaging within 
7 days after a TNA in about a quarter of patients [19]. This 
suggests that focal cerebral ischemia might play a role. 
From a clinical point of view, TNAs cannot be explained 
by a focal deficit in the brain. This is enhanced by the non-
focal nature of signs and symptoms accompanying TNAs, 
which makes it difficult for patients to express the signs 
and symptoms they have experienced. Even though focal 
cerebral ischemia is likely to play a role in the etiology of 
TNAs, the causal pathway between TNAs and focal isch-
emic lesions remains unclear. Whether these ischemic le-
sions are caused by embolism, local vasculopathy or hy-
poperfusion remains unanswered. 
Studies on the prevalence of TNAs are limited. Still, 
our study showed a relatively high prevalence (21%) of 
TNAs in the preceding 6 months. In a population-based 
study, 2% of patients 55 years or older experienced a TNA 
in the preceding 3 years [4]. However, in a hospital-based 
study, nonfocal symptoms occurred more frequently in 
patients with a recent TIA or nondisabling ischemic 
stroke [5]. In this study, 20% of patients without carotid 
or vertebral artery stenosis; 36% of patients with carotid 
artery stenosis; and 54% of patients with vertebral artery 
stenosis experienced nonfocal TNAs in the 6 months pre-
ceding the ischemic event [5]. We could not attribute the 
relatively high prevalence of TNAs in our study to cere-
bral hypoperfusion as a consequence of heart failure, nor 
to the duration of heart failure, the LVEF or NYHA clas-
sification as these characteristics of heart failure did not 
differ between patients with and without TNAs. Although 
we can only hypothesize, the relatively high prevalence of 
TNAs in patients with heart failure might be related to the 
relatively high prevalence of hypertension and angina 
pectoris in our patient population, as these factors were 
previously associated with the occurrence of TNAs in a 
population-based study [4]. 
Our finding that TNAs occurred more often in females 
than in males is different from a previous study in which 
similar male-female ratios were found in patients with 
TNAs, patients with TIAs, and in control participants 
without any neurological attacks [1]. These differences 
might depend on the classification of nonfocal symptoms 
that was used in each study as we have used “blurred vi-
sion” instead of “positive visual phenomena” and only 
“unconsciousness” instead of both “decreased conscious-
ness and unconsciousness” [1]. Besides, we did not in-
clude “unwell feelings” as a TNA [1]. 
Our study has some limitations. First, our results may 
have been influenced by recall bias as we could have 
missed TNAs that were not remembered by the patient. 
However, we used a standardized questionnaire that cov-
ered a broad spectrum of nonfocal symptoms. Second, we 
did not measure cerebral perfusion at the very moment of 
a TNA. Therefore, transient global cerebral hypoperfu-
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sion cannot be excluded as the cause of TNAs. We have 
no data on which activities were undertaken during each 
TNA or on the duration of TNAs in our cohort. However, 
as TNAs typically last < 1 h, measuring cerebral perfusion 
during a TNA is difficult [4]. Third, flow measurement by 
QMRA does not allow region specific assessment of cere-
bral perfusion, which precludes identification of local ar-
eas of hypoperfusion. Fourth, because we studied patients 
50 years or older with heart failure, the generalizability to 
a broader group of patients with TNAs is limited. How-
ever, our patient population was chosen deliberately, as 
patients with heart failure are vulnerable for cerebral hy-
poperfusion through a compromised cardiac output [7–
10]. 
Strengths of our study are that we, for the first time, 
report the frequency of TNAs in the specific population 
of patients with heart failure. Furthermore, all data were 
systematically collected by trained physicians or research 
nurses. 
In conclusion, our findings do not support global hy-
poperfusion of the brain as a risk factor for TNAs. Further 
studies are needed to unravel the possible mechanisms 
leading to TNAs.
Acknowledgments
We gratefully acknowledge the contribution of researchers and 
participants of the HBC consortium [12]. 
Statement of Ethics
Subjects have given their written informed consent. The study 
protocol has been approved by the research institute’s committee 
on human research.
Disclosure Statement
The authors have no conflicts of interest to declare. 
Funding Sources
The HBC consortium is supported by the Netherlands Cardio-
Vascular Research Initiative: the Dutch Heart Foundation (CVON 
2012-06 HBC), the Netherlands Organisation for Health Research 
and Development, and the Royal Netherlands Academy of Sci-
ences. C.J.M.K.: is supported by grants from the Dutch Heart 
Foundation (2012T077) and ZonMw (015008048).
References
 1 Bos MJ, van Rijn MJ, Witteman JC, Hofman 
A, Koudstaal PJ, Breteler MM. Incidence and 
prognosis of transient neurological attacks. 
JAMA. 2007 Dec; 298(24): 2877–85.
 2 A classification and outline of cerebrovascu-
lar diseases. II. Stroke. 1975 Sep-Oct; 6(5): 
564–616.
 3 Koudstaal PJ, Algra A, Pop GA, Kappelle 
LJ, van Latum JC, van Gijn J; The Dutch TIA 
Study Group. Risk of cardiac events in 
 atypical transient ischaemic attack or mi-
nor stroke. Lancet. 1992 Sep; 340(8820): 630–
3.
 4 Bots ML, van der Wilk EC, Koudstaal PJ, Hof-
man A, Grobbee DE. Transient neurological 
attacks in the general population. Prevalence, 
risk factors, and clinical relevance. Stroke. 
1997 Apr; 28(4): 768–73.
 5 Compter A, Kappelle LJ, Algra A, van der 
Worp HB. Nonfocal symptoms are more fre-
quent in patients with vertebral artery than 
carotid artery stenosis. Cerebrovasc Dis. 
2013; 35(4): 378–84.
 6 Plas GJ, Jurg SD, Brusse-keizer M, Dippel 
DW, Koudstaal PJ, den Hertog HM. N-Ter-
minal Pro-Brain Natriuretic Peptide (NT-
proBNP) levels are increased in patients with 
transient ischemic attack accompanied by 
nonfocal symptoms. J Am Heart Assoc. 2015 
Dec; 4(12):pii:e002072.
 7 Gruhn N, Larsen FS, Boesgaard S, Knudsen 
GM, Mortensen SA, Thomsen G, et al. 
 Cerebral blood flow in patients with chron-
ic  heart failure before and after heart 
 transplantation. Stroke. 2001 Nov; 32(11): 
2530–3.
 8 Choi BR, Kim JS, Yang YJ, Park KM, Lee CW, 
Kim YH, et al. Factors associated with de-
creased cerebral blood flow in congestive 
heart failure secondary to idiopathic dilated 
cardiomyopathy. Am J Cardiol. 2006 May; 
97(9): 1365–9.
 9 Paulson OB, Jarden JO, Godtfredsen J, Vor-
strup S. Cerebral blood flow in patients with 
congestive heart failure treated with captopril. 
Am J Med. 1984 May; 76(5 5B): 91–5.
10 Meng L, Hou W, Chui J, Han R, Gelb AW. 
Cardiac output and cerebral blood flow. An-
esthesiology. 2015 Nov; 123(5): 1198–208.
11 Ponikowski P, Voors AA, Anker SD, Bueno 
H, Cleland JG, Coats AJ, et al.; ESC Scientific 
Document Group. 2016 ESC Guidelines for 
the diagnosis and treatment of acute and 
chronic heart failure: the Task Force for the 
diagnosis and treatment of acute and chronic 
heart failure of the European Society of Car-
diology (ESC)Developed with the special con-
tribution of the Heart Failure Association 
(HFA) of the ESC. Eur Heart J. 2016 Jul; 
37(27): 2129–200.
12 Hooghiemstra AM, Bertens AS, Leeuwis AE, 
Bron EE, Bots ML, Brunner-La Rocca HP, et 
al.; Heart-Brain Connection Consortium. 
The missing link in the pathophysiology of 
vascular cognitive impairment: design of the 
Heart-Brain study. Cerebrovasc Dis Extra. 
2017; 7(3): 140–52.
13 Dolui S, Wang Z, Wang DJ, Mattay R, Fin-
kel M, Elliott M, et al. Comparison of non-
invasive MRI measurements of cerebral 
blood flow in a large multisite cohort. J 
Cereb Blood Flow Metab. 2016 Jul; 36(7): 
1244–56.
14 Spilt A, Box FM, van der Geest RJ, Reiber JH, 
Kunz P, Kamper AM, et al. Reproducibility 
of total cerebral blood flow measurements 
using phase contrast magnetic resonance im-
aging. J Magn Reson Imaging. 2002 Jul; 16(1): 
1–5.
15 Vernooij MW, van der Lugt A, Ikram MA, 
Wielopolski PA, Vrooman HA, Hofman A, et 
al. Total cerebral blood flow and total brain 
perfusion in the general population: the Rot-
terdam Scan Study. J Cereb Blood Flow 
Metab. 2008 Feb; 28(2): 412–9.
16 de Boer R, Vrooman HA, van der Lijn F, Ver-
nooij MW, Ikram MA, van der Lugt A, et al. 
White matter lesion extension to automatic 
brain tissue segmentation on MRI. Neuroim-
age. 2009 May; 45(4): 1151–61.
Oudeman et al.Cerebrovasc Dis 2019;47:303–308308
DOI: 10.1159/000502334
17 de Bono DP, Warlow CP, Hyman NM. Car-
diac rhythm abnormalities in patients pre-
senting with transient non-focal neurological 
symptoms: a diagnostic grey area? Br Med J 
(Clin Res Ed). 1982 May; 284(6327): 1437–9.
18 Plas GJ, Booij HA, Brouwers PJ, Brusse-Keiz-
er M, Koudstaal PJ, Dippel DW, et al. Nonfo-
cal symptoms in patients with transient isch-
emic attack or ischemic stroke: occurrence, 
clinical determinants, and association with 
cardiac history. Cerebrovasc Dis. 2016; 42(5-
6): 439–45.
19 van Rooij FG, Vermeer SE, Góraj BM, Koud-
staal PJ, Richard E, de Leeuw FE, et al. Diffu-
sion-weighted imaging in transient neurolog-
ical attacks. Ann Neurol. 2015 Dec; 78(6): 
1005–10.
